Login

Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Available-for-sale securities, current portion
Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively
Inventories
Prepaid expenses and other current assets
Current assets, discontinued operations
Total current assets
Assets held for rent, net
Property and equipment, net
Operating lease right-of-use assets, net
Financing lease right-of-use assets, net
Long-term deposits and other assets
Other assets
Available-for-sale securities, long-term
Equity investments
Intangible assets, net
Deferred tax assets, net
Goodwill
Long-term assets, discontinued operations
Total assets
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Sales taxes payable
Warranty liability
Lease liabilities, operating, current portion
Lease liabilities, financing, current portion
Debt, current portion
Contingent consideration, current portion
Current liabilities, discontinued operations
Total current liabilities
Contingent consideration, long-term
Lease liabilities, operating, long-term
Lease liabilities, financing, long-term
Debt, long-term
Deferred tax liabilities
Other long-term liabilities
Long-term liabilities, discontinued operations
Total liabilities
Shareholders’ equity:
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated other comprehensive (loss) income, net of tax
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support